IL111080A - Method for treating a finely divided powder medicament - Google Patents
Method for treating a finely divided powder medicamentInfo
- Publication number
- IL111080A IL111080A IL11108094A IL11108094A IL111080A IL 111080 A IL111080 A IL 111080A IL 11108094 A IL11108094 A IL 11108094A IL 11108094 A IL11108094 A IL 11108094A IL 111080 A IL111080 A IL 111080A
- Authority
- IL
- Israel
- Prior art keywords
- finely divided
- treating
- divided powder
- powder medicament
- agglomerates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/20—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by expressing the material, e.g. through sieves and fragmenting the extruded length
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Control Of Multiple Motors (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Stereophonic System (AREA)
- Exchange Systems With Centralized Control (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Mixers Of The Rotary Stirring Type (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- General Preparation And Processing Of Foods (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9303214A SE9303214D0 (sv) | 1993-10-01 | 1993-10-01 | Process I |
SE9304271A SE9304271D0 (sv) | 1993-12-22 | 1993-12-22 | Process I |
US08/317,033 US5551489A (en) | 1993-10-01 | 1994-10-03 | Agglomeration of finely divided powders |
Publications (2)
Publication Number | Publication Date |
---|---|
IL111080A0 IL111080A0 (en) | 1994-11-28 |
IL111080A true IL111080A (en) | 1999-08-17 |
Family
ID=27355730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11108094A IL111080A (en) | 1993-10-01 | 1994-09-29 | Method for treating a finely divided powder medicament |
Country Status (23)
Country | Link |
---|---|
US (1) | US5551489A (zh) |
EP (1) | EP0721331B1 (zh) |
JP (1) | JP3732508B2 (zh) |
CN (1) | CN1110300C (zh) |
AT (1) | ATE209903T1 (zh) |
AU (1) | AU679789B2 (zh) |
BR (1) | BR9407686A (zh) |
CZ (1) | CZ289214B6 (zh) |
DE (1) | DE69429357T2 (zh) |
DK (1) | DK0721331T3 (zh) |
EG (1) | EG20677A (zh) |
ES (1) | ES2166786T3 (zh) |
FI (1) | FI116364B (zh) |
HU (1) | HU222355B1 (zh) |
IL (1) | IL111080A (zh) |
NO (1) | NO314836B1 (zh) |
NZ (1) | NZ274277A (zh) |
PL (1) | PL175564B1 (zh) |
PT (1) | PT721331E (zh) |
RU (1) | RU2170082C2 (zh) |
SG (1) | SG48049A1 (zh) |
SK (1) | SK283569B6 (zh) |
WO (1) | WO1995009615A1 (zh) |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9404945D0 (en) * | 1994-03-15 | 1994-04-27 | Glaxo Group Ltd | Pharmaceutical composition |
US5983956A (en) * | 1994-10-03 | 1999-11-16 | Astra Aktiebolag | Formulation for inhalation |
SE9700136D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
US5980949A (en) * | 1994-10-03 | 1999-11-09 | Astra Aktiebolag | Formulation for inhalation |
SE9700134D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
US5654007A (en) * | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
DE19522899C1 (de) * | 1995-06-23 | 1996-12-19 | Hexal Pharmaforschung Gmbh | Verfahren zum kontinuierlichen Ersintern eines Granulats |
US5826633A (en) * | 1996-04-26 | 1998-10-27 | Inhale Therapeutic Systems | Powder filling systems, apparatus and methods |
US20020052310A1 (en) * | 1997-09-15 | 2002-05-02 | Massachusetts Institute Of Technology The Penn State Research Foundation | Particles for inhalation having sustained release properties |
US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US6652837B1 (en) | 1996-05-24 | 2003-11-25 | Massachusetts Institute Of Technology | Preparation of novel particles for inhalation |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
SE9700133D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
US6495167B2 (en) | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
EP0969816B1 (en) * | 1997-03-20 | 2004-12-15 | Schering Corporation | Preparation of powder agglomerates |
US6503537B2 (en) | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
EP0876814A1 (en) * | 1997-05-07 | 1998-11-11 | "PHARLYSE", Société Anonyme | Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it |
US6182712B1 (en) | 1997-07-21 | 2001-02-06 | Inhale Therapeutic Systems | Power filling apparatus and methods for their use |
US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
WO1999036095A1 (en) * | 1998-01-13 | 1999-07-22 | Astrazeneca Uk Limited | PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D2) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING β2-ADRENORECEPTOR AGONIST ACTIVITY |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
US8722668B2 (en) * | 1998-12-23 | 2014-05-13 | Daryl W. Hochman | Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders |
US6749835B1 (en) | 1999-08-25 | 2004-06-15 | Advanced Inhalation Research, Inc. | Formulation for spray-drying large porous particles |
WO2001013891A2 (en) * | 1999-08-25 | 2001-03-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
US20010036481A1 (en) * | 1999-08-25 | 2001-11-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
US7304750B2 (en) | 1999-12-17 | 2007-12-04 | Nektar Therapeutics | Systems and methods for non-destructive mass sensing |
US6499984B1 (en) * | 2000-05-22 | 2002-12-31 | Warner-Lambert Company | Continuous production of pharmaceutical granulation |
EP1345629A2 (en) * | 2000-12-29 | 2003-09-24 | Advanced Inhalation Research, Inc. | Particles for inhalation having sustained release properties |
US20020141946A1 (en) * | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
HU229224B1 (en) | 2001-02-14 | 2013-09-30 | Tibotec Pharmaceuticals Ltd Little Island | 2-(substituted-amino)-benzothiazole sulfonamide compounds having broadspectrum hiv protease inhibitor activity and medicaments containing them |
OA12464A (en) | 2001-04-09 | 2006-05-24 | Tibotec Pharm Ltd | Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors. |
DK1387842T3 (da) | 2001-05-11 | 2009-08-10 | Tibotec Pharm Ltd | Bredspektrede 2-amino-benzoxazolsulfonamid-HIV-protease-inhibitorer |
WO2003043585A2 (en) * | 2001-11-20 | 2003-05-30 | Advanced Inhalation Research, Inc. | Improved particulate compositions for pulmonary delivery |
US20030129250A1 (en) * | 2001-11-20 | 2003-07-10 | Advanced Inhalation Research Inc. | Particulate compositions for improving solubility of poorly soluble agents |
MY138657A (en) | 2001-12-21 | 2009-07-31 | Tibotec Pharm Ltd | broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
MY142238A (en) | 2002-03-12 | 2010-11-15 | Tibotec Pharm Ltd | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
JP4674084B2 (ja) | 2002-05-17 | 2011-04-20 | テイボテク・フアーマシユーチカルズ・リミテツド | 広域スペクトルの置換ベンズイソキサゾールスルホンアミドhivプロテアーゼ阻害剤 |
NZ538714A (en) | 2002-08-14 | 2007-03-30 | Tibotec Pharm Ltd | Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors |
EP1417958A1 (en) * | 2002-11-08 | 2004-05-12 | Pari GmbH | Wet granulation process |
TW200518742A (en) | 2003-09-11 | 2005-06-16 | Tibotec Pharm Ltd | Entry inhibitors |
SE528121C2 (sv) * | 2004-03-29 | 2006-09-05 | Mederio Ag | Preparering av torrpulver för på förhand uppmätt DPI |
AR048650A1 (es) | 2004-05-04 | 2006-05-10 | Tibotec Pharm Ltd | Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih |
MXPA06012909A (es) | 2004-05-07 | 2007-09-06 | Sequoia Pharmaceuticals Inc | Inhibidores de proteasa retroviral repelente de resistencia. |
TW200613307A (en) | 2004-05-17 | 2006-05-01 | Tibotec Pharm Ltd | 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
MXPA06013314A (es) | 2004-05-17 | 2007-02-02 | Tibotec Pharm Ltd | 1-heterociclil-1,5-dihidro-pirido[3,2-b]indol-2-onas. |
US7622581B2 (en) | 2004-05-17 | 2009-11-24 | Tibotec Pharmaceuticals Ltd. | 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents |
TW200710091A (en) | 2005-04-11 | 2007-03-16 | Tibotec Pharm Ltd | (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors |
US8003627B2 (en) | 2005-10-21 | 2011-08-23 | Universiteit Antwerpen | Urokinase inhibitors |
EP2004647A1 (en) | 2006-04-03 | 2008-12-24 | Tibotec Pharmaceuticals Ltd. | Hiv inhibiting 3,4-dihydro-imidazoý4,5-b¨pyridin-5-ones |
DE102007049931A1 (de) | 2007-10-18 | 2009-04-23 | Pharmatech Gmbh | Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten |
EP2116236A1 (en) | 2008-04-21 | 2009-11-11 | Université de Mons-Hainaut | Bisbenzamidine derivatives for use as antioxidant |
EP2421518A2 (en) * | 2009-04-24 | 2012-02-29 | Schering Corporation | Agglomerate formulations including active pharmaceutical agents with targeted particle sizes |
PT2542528E (pt) | 2010-03-02 | 2013-09-09 | Amakem Nv | Aminas heterociclicas como inibidores rock |
WO2011110852A1 (en) | 2010-03-10 | 2011-09-15 | Astrazeneca Ab | Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide |
GB201019043D0 (en) | 2010-11-10 | 2010-12-22 | Protea Biopharma N V | Use of 2',5'-oligoadenylate derivative compounds |
GB201102237D0 (en) | 2011-02-09 | 2011-03-23 | Kuecept Ltd | Particle formulation |
GB201108225D0 (en) | 2011-05-17 | 2011-06-29 | Amakem Nv | Novel KBC inhibitors |
GB201113689D0 (en) | 2011-08-09 | 2011-09-21 | Amakem Nv | Novel PDE4 inhibitors |
GB201114854D0 (en) | 2011-08-29 | 2011-10-12 | Amakem Nv | Novel rock inhibitors |
WO2013030365A1 (en) | 2011-08-31 | 2013-03-07 | Amakem Nv | Novel rock kinase inhibitors |
DK2760867T3 (en) | 2011-09-30 | 2016-04-11 | Oncodesign Sa | Macrocyclic FLT3 kinase inhibitors |
EP2760453B1 (en) | 2011-09-30 | 2016-05-25 | Ipsen Pharma S.A.S. | Macrocyclic lrrk2 kinase inhibitors |
ES2958619T3 (es) | 2012-01-30 | 2024-02-12 | Univ Gent | Compuestos anti-invasivos |
GB201204756D0 (en) | 2012-03-19 | 2012-05-02 | Lewi Paulus J | Triazines with suitable spacers for treatment and/or prevention of HIV infections |
WO2014072419A1 (en) | 2012-11-08 | 2014-05-15 | Universiteit Antwerpen | Novel anti-hiv compounds |
BR112015022650A8 (pt) | 2013-03-15 | 2018-01-23 | Oncodesign Sa | inibidores de quinase induzível por sal macrocíclico. |
US9427376B2 (en) * | 2013-10-10 | 2016-08-30 | Chiesi Farmaceutici S.P.A. | Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient |
WO2015150337A1 (en) | 2014-04-01 | 2015-10-08 | Amakem Nv | Lim kinase inhibitors |
EP3180003B1 (en) | 2014-07-01 | 2022-01-12 | The Regents of the University of California | Pkc-epsilon inhibitors |
EP3166955B1 (en) | 2014-07-08 | 2018-05-02 | Universiteit Gent | Hamamelitannin analogues and uses thereof |
CN107108641A (zh) | 2014-09-17 | 2017-08-29 | 昂科迪塞恩股份有限公司 | 大环lrrk2激酶抑制剂 |
WO2016042087A1 (en) | 2014-09-17 | 2016-03-24 | Oncodesign S.A. | Macrocyclic rip2 kinase inhibitors |
WO2016083490A1 (en) | 2014-11-27 | 2016-06-02 | Remynd Nv | Compounds for the treatment of amyloid-associated diseases |
WO2016146651A1 (en) | 2015-03-16 | 2016-09-22 | Oncodesign Sa | Macrocyclic activin-like receptor kinase inhibitors |
WO2017146994A1 (en) * | 2016-02-24 | 2017-08-31 | Merck Sharp & Dohme Corp. | Controlled agglomeration of micronized drug or drug-excipient mixtures |
WO2017157882A1 (en) | 2016-03-14 | 2017-09-21 | Université Catholique de Louvain | Serine biosynthetic pathway inhibitors |
WO2018065387A1 (en) | 2016-10-04 | 2018-04-12 | Universiteit Gent | Novel hamamelitannin analogues and uses thereof |
US10738002B2 (en) | 2016-11-24 | 2020-08-11 | Universitair Ziekenhuis Antwerpen | Halogenated benzotropolones as ATG4B inhibitors |
WO2018138358A1 (en) | 2017-01-30 | 2018-08-02 | Université de Liège | Perk and ire-1a inhibitors against neurodevelopmental disorders |
EA201992397A1 (ru) | 2017-05-11 | 2020-03-16 | Реминд Н.В. | Соединения для лечения эпилепсии, нейродегенеративных нарушений и других нарушений цнс |
EP3773562A1 (en) | 2018-04-05 | 2021-02-17 | Universiteit Hasselt | Selective pde4d inhibitors against demyelinating diseases |
CA3110661A1 (en) | 2018-08-29 | 2020-03-05 | University Of Massachusetts | Inhibition of protein kinases to treat friedreich ataxia |
JP7370032B2 (ja) | 2019-05-14 | 2023-10-27 | スーヂョウ フォー ヘルス ファーマスーティカルズ カンパニー リミテッド | Parr阻害剤としてのキナゾリン―2.4―ジオン誘導体 |
WO2022157381A1 (en) | 2021-01-25 | 2022-07-28 | Universiteit Hasselt | Phloretin for use in the treatment of neurodegenerative and demyelinating diseases |
WO2023021132A1 (en) | 2021-08-18 | 2023-02-23 | Katholieke Universiteit Leuven | 6-substituted- and 6,7-disubstituted-7-deazapurine ribonucleoside analogues |
WO2023046900A1 (en) | 2021-09-23 | 2023-03-30 | Katholieke Universiteit Leuven | Ribonucleoside analogues against -sars-cov-2 |
WO2023241799A1 (en) | 2022-06-15 | 2023-12-21 | Université Libre de Bruxelles | Flavanols for use in the treatment of retroviral infections |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2609150A (en) * | 1949-11-05 | 1952-09-02 | Union Carbide & Carbon Corp | Mechanical pulverization of refrigerated plastics |
NL128302C (zh) * | 1960-03-25 | 1900-01-01 | ||
GB1242211A (en) * | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
US3802822A (en) * | 1972-03-01 | 1974-04-09 | Mars Mineral Corp | Pelletizer |
GB1569611A (en) * | 1976-01-23 | 1980-06-18 | Fisons Ltd | Pelletised or granular medicament formulation |
GB1520247A (en) * | 1974-08-10 | 1978-08-02 | Fisons Ltd | Pelletised medicament formulations |
US4161516A (en) * | 1975-07-25 | 1979-07-17 | Fisons Limited | Composition for treating airway disease |
US4161526A (en) * | 1978-07-20 | 1979-07-17 | Sterling Drug Inc. | Zinc salt prevention or removal of discoloration in pyrithione, pyrithione salt and dipyrithione compositions |
DE3268533D1 (en) * | 1981-07-24 | 1986-02-27 | Fisons Plc | Inhalation drugs, methods for their production and pharmaceutical formulations containing them |
US4688610A (en) * | 1985-03-19 | 1987-08-25 | Spiral Systems Inc. | Apparatus for dispensing particulate agglomerating solids |
US4940556A (en) * | 1986-01-30 | 1990-07-10 | Syntex (U.S.A.) Inc. | Method of preparing long acting formulation |
GB8606762D0 (en) * | 1986-03-19 | 1986-04-23 | Boots Co Plc | Therapeutic agents |
JPS63116732A (ja) * | 1986-11-06 | 1988-05-21 | Fukae Kogyo Kk | 粉粒体処理装置 |
GB8711005D0 (en) * | 1987-05-09 | 1987-06-10 | British Petroleum Co Plc | Chemical process |
ES2044710T3 (es) * | 1990-01-29 | 1994-01-01 | Ciba Geigy Ag | Procedimiento y dispositivo de dosificacion de un polvo de granulometria fina. |
GB9027018D0 (en) * | 1990-12-12 | 1991-01-30 | Ici Plc | Heterocyclic compounds |
US5394868A (en) * | 1992-06-25 | 1995-03-07 | Schering Corporation | Inhalation device for powdered medicaments |
-
1994
- 1994-09-29 RU RU96108803/14A patent/RU2170082C2/ru active
- 1994-09-29 PL PL94313765A patent/PL175564B1/pl unknown
- 1994-09-29 ES ES94929076T patent/ES2166786T3/es not_active Expired - Lifetime
- 1994-09-29 CN CN94193634A patent/CN1110300C/zh not_active Expired - Lifetime
- 1994-09-29 SG SG1996006659A patent/SG48049A1/en unknown
- 1994-09-29 SK SK391-96A patent/SK283569B6/sk not_active IP Right Cessation
- 1994-09-29 IL IL11108094A patent/IL111080A/xx not_active IP Right Cessation
- 1994-09-29 EG EG60594A patent/EG20677A/xx active
- 1994-09-29 DE DE69429357T patent/DE69429357T2/de not_active Expired - Lifetime
- 1994-09-29 AU AU78261/94A patent/AU679789B2/en not_active Expired
- 1994-09-29 DK DK94929076T patent/DK0721331T3/da active
- 1994-09-29 CZ CZ1996942A patent/CZ289214B6/cs not_active IP Right Cessation
- 1994-09-29 JP JP51074895A patent/JP3732508B2/ja not_active Expired - Lifetime
- 1994-09-29 BR BR9407686A patent/BR9407686A/pt not_active IP Right Cessation
- 1994-09-29 WO PCT/SE1994/000896 patent/WO1995009615A1/en active IP Right Grant
- 1994-09-29 PT PT94929076T patent/PT721331E/pt unknown
- 1994-09-29 EP EP94929076A patent/EP0721331B1/en not_active Expired - Lifetime
- 1994-09-29 HU HU9600821A patent/HU222355B1/hu active IP Right Grant
- 1994-09-29 AT AT94929076T patent/ATE209903T1/de active
- 1994-09-29 NZ NZ274277A patent/NZ274277A/en not_active IP Right Cessation
- 1994-10-03 US US08/317,033 patent/US5551489A/en not_active Expired - Lifetime
-
1996
- 1996-03-29 FI FI961430A patent/FI116364B/fi not_active IP Right Cessation
- 1996-03-29 NO NO19961290A patent/NO314836B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL111080A (en) | Method for treating a finely divided powder medicament | |
TW374728B (en) | Method of treatment of finely divided powdered medicament and apparatus for forming powdered medicament | |
EP0831782A4 (en) | METHOD AND SYSTEM FOR TREATING DISPERSABLE FINE POWDER | |
GB9313650D0 (en) | Method and apparatus for the formation of particles | |
GB9606677D0 (en) | Process and device | |
PL310982A1 (en) | Blood flow stimulating preparation containing magnetically hard particles | |
GB2216535B (en) | "process for producing polyorganosilsesquioxane spherical particles" | |
ZA888117B (en) | Particle type agent for removing ionic constituents from aqueous solutions,process for the production of this agent its use | |
EP0130043A3 (en) | Magnetizable adsorbents | |
EP0606930A3 (en) | Process for preparation of polymer particles, process for preparation of toner particles and particles prepared according to these processes. | |
ZA83321B (en) | Method of,and arrangement for,reducing oxide-containing fine particle ores | |
AU581530B2 (en) | Process for the preparation of granules and granules obtained by this process | |
MX9504457A (es) | Polvo de flujo libre para moldeo que comprende politetrafluoroetileno. | |
EP0669135A4 (en) | GRANULAR PREPARATION FOR MRI. | |
OA09635A (en) | Sintered high titanium agglomerates | |
MY113971A (en) | Process 11. | |
CA2172053A1 (en) | Process (i) for the preparation of powdered medicament | |
EP0641587A3 (de) | Verfahren zum Auftrennen einer Dispersion von Partikeln in Flüssigkeiten in einen mit Partikeln angereicherten und einen an Partikeln verarmten Teilstrom. | |
MY111802A (en) | Agglomeration of finely divided powders. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |